Evidence map›Paper›PMID 8897201›Full record

ArticleJournal of clinical microbiology1996

Characterization of nonmotile variants of Escherichia coli O157 and other serotypes by using an antiflagellin monoclonal antibody.

P Feng, P I Fields, B Swaminathan, T S Whittam

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Foodborne illnesses ofJournal of food science and technology · 2023
    Review
  2. Review
  3. Article
  4. Pathogenomes of Atypical Non-shigatoxigenicFrontiers in microbiology · 2020
    Article
  5. Variability in CharacterizingMicroorganisms · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Diarrheagenic Escherichia coli.Clinical microbiology reviews · 1998
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

P FengDivision of Microbiological Studies, Food and Drug Administration, Washington, D.C. 20204, USA. pxf@fdacf.ssw.dhhs.gov
P I Fields
B Swaminathan
T S Whittam

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An antiflagellin monoclonal antibody (15D8) was used to detect the presence of flagella in nonmotile variants of several pathogenic Escherichia coli serotypes. Of the 48 isolates examined, 15 reacted with monoclonal antibody 15D8 and were culturally confirmed to be motile. Of the 38 clinical strains designated O157:NM or O157:H-, 7 were antibody reactive and motile and agglutinated with anti-H7 sera.

Indexed as

Antibodies, MonoclonalBlotting, WesternEscherichia coli InfectionsEscherichia coli O157FlagellaFlagellinGenetic VariationHumansMovementSerotypingSpecies SpecificityVirulenceAntibodies, MonoclonalFlagellin

Identifiers

PMID8897201
PMCPMC229422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.